Clinical Trial Update: Pharmacokinetic Study to Evaluate Safety and Tolerability of EG-101 in Healthy Female Volunteers as a Safety Lead-In for Dosing in Pregnant Women With Severe Pre-eclampsia [Phase 1]

View source ↗

Summary

This is a Phase 1 pharmacokinetic safety study evaluating EG-101 in healthy female volunteers as a safety lead-in for dosing in pregnant women with severe preec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preeclampsia

Drugs mentioned

• EG-101

Snippet

Sponsor: Evergreen Therapeutics, Inc. | Conditions: Pre-eclampsia | Phase 1 | Status: NOT_YET_RECRUITING